Search results
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 2 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 5 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 1 day agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive via Yahoo Finance· 6 days agoCerevel Therapeutics, a biotechnology company in the midst of being acquired by AbbVie, on Thursday...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 6 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 6 hours agoThe following day, i.e., on Apr 26, AbbVie ABBV is slated to release its first-quarter results...
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 5 days agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 6 days agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...